Industry

Study entitled “Reducing Pre-analytical Sample QC Failure Rates for Cancer Molecular Genetic Assays with SLIMamp® Technology” published in conjunction with the American Society of Clinical Oncology (ASCO) 2022 Annual Meeting NATICK, Mass.–(BUSINESS WIRE)–Pillar Biosciences, the leader in Decision Medicine™, which develops and distributes next-generation sequencing (NGS) tests to localize testing and reduce time to treatment … [Read more…]

DANVERS, Mass.–(BUSINESS WIRE)–Abiomed, Inc. (NASDAQ: ABMD), a leader in breakthrough heart, lung and kidney support technologies, today announced that Michael R. Minogue, Chairman, President and Chief Executive Officer, will present (live) at the William Blair 42nd Annual Growth Stock Conference on Monday, June 6, 2022 at 2:00pm CT. ABOUT ABIOMED Based in Danvers, Massachusetts, USA, … [Read more…]

Additionally, analysis of two-year physiological range of motion data from multiple artificial cervical disc IDE studies to be presented showing benefits of the nucleus-annulus design of the M6-C disc LEWISVILLE, Texas–(BUSINESS WIRE)–Orthofix Medical Inc. (NASDAQ:OFIX), a global medical device company with a spine and orthopedics focus, today announced the presentation of five-year data from the … [Read more…]

A Collection of Practical Tools and Techniques for Daily Development FORT LAUDERDALE, Fla.–(BUSINESS WIRE)–James Miller and LIFEOLOGY® | Publishing today announced the publication of LIFE LESSONS: You are the Expert on Your Life | A Workbook. “LIFE LESSONS is designed to help you focus on what already works for you,” James Miller says, “the book … [Read more…]

PHILADELPHIA–(BUSINESS WIRE)–Seneca Therapeutics, Inc. (STI), a clinical-stage biopharmaceutical company dedicated to the development of novel immunotherapies for difficult to treat solid cancers, announced today that Cuong Do, a longtime industry veteran has joined the Seneca Therapeutics Advisory Board. Mr. Do is also an investor in Seneca Therapeutics. “We are pleased that Cuong has agreed to … [Read more…]

IRVINE, Calif.–(BUSINESS WIRE)–Axonics, Inc. (Nasdaq: AXNX), a global medical technology company that is developing and commercializing novel products for the treatment of bladder and bowel dysfunction, has filed a premarket approval supplement with the FDA for its fourth generation rechargeable sacral neuromodulation implantable neurostimulator (INS). The fourth generation rechargeable INS reduces how frequently a patient … [Read more…]

BOCA RATON, Fla.–(BUSINESS WIRE)–TherapeuticsMD, Inc. (NASDAQ: TXMD) (“TherapeuticsMD,” “TXMD” or the “Company”), an innovative, leading women’s healthcare company, today announced that it has entered into a definitive merger agreement to be acquired by an affiliate of EW Healthcare Partners, a private equity firm dedicated to making investments in rapidly growing healthcare companies. Under the terms … [Read more…]

Company CEO and CBO will be available throughout BIO 2022 for partnering meetings RICHMOND, Calif.–(BUSINESS WIRE)–BioAge Labs, Inc. (“BioAge”, “the Company”), a biotechnology company developing therapeutics that target the molecular causes of aging to extend healthy human lifespan, today announced that Kristen Fortney, PhD, CEO and Co-Founder of BioAge, will lead a panel discussion at … [Read more…]

TAIPEI, Taiwan–(BUSINESS WIRE)–On May 31st, 2022 Chunghwa Telecom Co., Ltd. (CHT) and Thonburi Hospital (TH) signed the “Smart Hospital” MOU. In light of the government of Thailand’s “Medical Hub of Asia” strategy in 2004, and its goal to become the leading Southeast Asian countries in providing international healthcare services, the two parties, CHT and TH, … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Global Oral Rehydration Salt Market Research Report 2022 (Status and Outlook)” report has been added to ResearchAndMarkets.com’s offering. The Global Oral Rehydration Salt Market Size was estimated at USD 646.1 million in 2021 and is projected to reach USD 958.7 million by 2028, exhibiting a CAGR of 6.80% during the forecast period. The … [Read more…]